O POSITIV, INC. – Trademark Portfolio
Entity Type: 03
O POSITIV, INC. holds 53 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 46 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 24 trademarks are registered and 10 are pending. Notable registered marks include O+, FLO, URO, GOGO, and GTFO. The owner is based in LOS ANGELES, CA.
11740 SAN VICENTE BLVD. SUITE 109-333
LOS ANGELES, CA 90049
Showing of trademarks Trademarks
Trademark Classifications
O POSITIV, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does O POSITIV, INC. have?
O POSITIV, INC. has 53 U.S. trademarks filed with the USPTO. Of these, 24 registered, 10 pending, 17 abandoned, 2 cancelled.
What trademark classes does O POSITIV, INC. file in?
O POSITIV, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are O POSITIV, INC.'s most well-known trademarks?
O POSITIV, INC.'s registered trademark portfolio includes well-known marks such as O+, FLO, URO, GOGO, and GTFO. These are among 24 currently registered trademarks in the portfolio.
What is O POSITIV, INC.'s trademark registration success rate?
O POSITIV, INC. has a 56% trademark registration rate, with 24 out of 43 resolved applications resulting in successful registration. Currently, 10 applications are pending review.